Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 16,511Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12BAUSCH

02 3MAYNE PHARMA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

HALOBETASOL PROPIONATE; TAZAROTENE

US Patent Number : 10478502

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209354

Patent Use Code : U-2625

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-11-02

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

HALOBETASOL PROPIONATE; TAZAROTENE

US Patent Number : 10426787

Drug Substance Claim :

Drug Product Claim :

Application Number : 209354

Patent Use Code : U-2625

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-06-06

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

HALOBETASOL PROPIONATE; TAZAROTENE

US Patent Number : 11648256

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209354

Patent Use Code : U-2625

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-06-06

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TAZAROTENE

US Patent Number : 11311482

Drug Substance Claim :

Drug Product Claim :

Application Number : 211882

Patent Use Code : U-2368

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-05-11

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

HALOBETASOL PROPIONATE; TAZAROTENE

US Patent Number : 11679115

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209354

Patent Use Code : U-2625

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-06-06

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

HALOBETASOL PROPIONATE; TAZAROTENE

US Patent Number : 11839656

Drug Substance Claim :

Drug Product Claim :

Application Number : 209354

Patent Use Code : U-2625

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-11-02

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

HALOBETASOL PROPIONATE; TAZAROTENE

US Patent Number : 11986527

Drug Substance Claim :

Drug Product Claim :

Application Number : 209354

Patent Use Code : U-2625

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-11-02

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TAZAROTENE

US Patent Number : 11679116

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211882

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-06-06

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

HALOBETASOL PROPIONATE; TAZAROTENE

US Patent Number : 12076403

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209354

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-11-02

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

HALOBETASOL PROPIONATE; TAZAROTENE

US Patent Number : 10251895

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209354

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-06-06

blank